Identifying PFAS-induced disruption of placental imprinting and neurodevelopment through multi-omic negative control calibration

Active Grant Awarded Last action

Award ID
R21ES039048
Recipient
Awarding agency
Obligated
$241,317

Award facts

Assistance listing
93.113 Environmental Health
Completion date 10% complete
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

About this award

The National Institute of Environmental Health Sciences, within the Department of Health and Human Services' National Institutes of Health, awarded Grant R21ES039048 to The University of Texas M.D. Anderson Cancer Center (doing business as MD Anderson Cancer Center) on September 9, 2026, obligating $241,317 under the Environmental Health program (CFDA 93.113). The project tests whether gestational PFAS exposure disrupts transcript-isoform imprinting in placental neurodevelopment-associated pathways, leading to altered offspring social responsiveness. Aim 1 characterizes PFAS-associated changes to placental parent-of-origin isoform regulation using negative binomial generalized linear mixed models for expression data and beta regression models for DNA methylation data, with cell-type deconvolution identifying vulnerable genomic regions across eight PFAS compounds. Aim 2 develops and validates SCENIC, an R package implementing four causal inference approaches that use generative adversarial networks. The work draws on two birth cohorts, GUSTO (N=102) and ELGAN (N=86), combining parent-offspring genotypes, maternal PFAS measurements, placental multi-omics data, and neurodevelopmental assessments. The period of performance runs through August 31, 2028, with place of performance in Houston, Texas 77030.

Description

Abstract
While prenatal exposure to per- and polyfluoroalkyl substances (PFAS) is linked to altered neurodevelopmental outcomes including impaired social responsiveness, the mechanistic pathways connecting environmental exposure through placental genomic imprinting to offspring neurodevelopment remain poorly understood. Additionally, prioritizing potential causal links between environmental exposures and developmental outcomes in observational cohort studies is limited by unmeasured confounding, requiring improved statistical methods that leverage multi-omic data to distinguish true mediating pathways from spurious associations. PFAS are ubiquitous environmental contaminants detected in over 95% of pregnant women worldwide, with prenatal exposure associated with social responsiveness scale deficits. The placenta serves as the critical interface mediating these effects through epigenetic mechanisms including genomic imprinting and alternative splicing that are particularly vulnerable to chemical exposures. We hypothesize that gestational PFAS exposure disrupts transcript-isoform imprinting in placental neurodevelopment-associated pathways, leading to altered offspring social responsiveness. This project leverages two birth cohorts with parent-offspring genotypes, maternal PFAS measurements, placental multi-omics data, and neurodevelopmental assessments (gusto, N=102; elgan, N=86). Aim 1 will characterize PFAS-associated changes to placental parent-of-origin isoform regulation using negative binomial generalized linear mixed models for expression data and beta regression models for DNA methylation data. Cell-type deconvolution will identify vulnerable genomic regions across eight PFAS compounds. Aim 2 will develop and validate scenic, an R package implementing four causal inference approaches using generative adversarial networks to address unmeasured confounding. We will then test whether PFAS-induced placental imprinting disruptions mediate effects on infant social responsiveness. This research addresses critical gaps by advancing beyond gene-level analyses to isoform-specific, cell-type-aware approaches while providing methodological innovations for molecular epidemiology and environmental health research. Expected outcomes include identification of 10-20 genes and 30-80 isoforms with significant PFAS × parent-of-origin interactions per compound, validation of mediation pathways, and a causal inference R package. This work will inform understanding of PFAS effects on genomic imprinting and guide targeted interventions during critical developmental windows.

Transactions

Action Obligated Date
Amendment $0
Original award $241,317

Quick answers

Who received award R21ES039048?

R21ES039048 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Institute of Environmental Health Sciences (National Institutes of Health) on September 9, 2026.

How much is award R21ES039048 worth?

$241,317 has been obligated on R21ES039048.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award